What Patients Want
Most pharma companies want to become more patient focused. But how? You could start by simply listening more carefully.
Abbe Steel |
Are the pharmaceutical industry's clinical development programs more patient-centered than they used to be? Well, there is certainly a lot more talk about ‘patient-centric’ clinical trials. But if I were to pick up a protocol from today and compare it with a similar trial 10 years ago, I doubt I would notice a significant change in design or concept.
Do we think more about the patient than we used to? Yes... And yet, in over 20 years in the industry, I have seen countless missed opportunities to involve patients. For years, I worked on studies and programs that relied on patient involvement, and I saw first-hand the same problems again and again. Recruitment would fall behind, trials went over-budget, and patients had recurring complaints. Many of these issues stemmed from the original trial protocol; I wanted to find out where we were going wrong and how we could do better. The most obvious place to start was to talk with the patients. Surprisingly, this is still a novel concept.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.